MIMahwish Ilyas

Mahwish Ilyas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mahwish Ilyas has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An efficient leukemia prediction method using machine learning and deep learning with selected features

    by Mahwish Ilyas, Muhammad Ramzan, Mohamed Deriche, Khalid Mahmood, Anam Naz

    Leukemia is a serious problem affecting both children and adults, leading to death if left untreated. Leukemia is a kind of blood cancer described by the rapid proliferation of abnormal blood cells. An early, trustworthy, and precise identification of leukemia is important to treating and saving patients’ lives. Acute and myelogenous lymphocytic, chronic and myelogenous leukemia are the four kinds of leukemia. Manual inspection of microscopic images is frequently used to identify these malignant growth cells. Leukemia symptoms include fatigue, a lack of enthusiasm, a dull appearance, recurring illnesses, and easy blood loss. Identifying subtypes of leukemia for specialized therapy is one of the hurdles in this area. The suggested work predicts and classifies leukemia subtypes in gene data CuMiDa (GSE9476) using feature selection and ML techniques. The Curated Microarray Database (CuMiDa) collected 64 samples representing five classes of leukemia genes out of 22283 genes. The proposed approach utilizes the 25 most differentiating selected features for classification using machine and deep learning techniques. This study has a classification accuracy of 96.15% using Random Fores, 92.30 using Linear Regression, 96.15% using SVM, and 100% using LSTM. Deep learning methods have been shown to outperform traditional methods in leukemia gene classification by utilizing specific features.


  • Open Access

    Using Deep Learning Techniques to Enhance Blood Cell Detection in Patients with Leukemia

    by Mahwish Ilyas, Muhammad Bilal, Nadia Malik, Hikmat Ullah Khan, Muhammad Ramzan, Anam Naz

    Medical diagnosis plays a critical role in the early detection and treatment of diseases by examining symptoms and supporting findings through advanced laboratory testing. Early and accurate diagnosis is essential for detecting medical problems and then prescribing the most effective treatment strategies, especially in life-threatening diseases such as leukemia. Leukemia, a blood malignancy, is one of the most prevalent cancer types affecting both adults and children. It is caused by the rapid and uncontrolled growth of abnormal white blood cells in the bone marrow. This accumulation interferes with the production of normal blood cells, leading to a weakened immune deficiency, anemia, and bleeding disorders. Conventional leukemia diagnostic methods are time-consuming, manually intensive, and inefficient. This research study proposes an automatic diagnostics prediction of leukemia by analyzing blood images according to the shape of the blast cells using digital image processing and machine learning. The purpose of blood cell detection is to precisely identify and classify diverse blood cells, detecting anomalies associated with blood cancers like leukemia. This supports early diagnosis and monitoring, which leads to more effective treatments and improved results for cancer patients. To accomplish this task, we use digital image processing techniques and then apply the convolutional neural network (CNN) deep learning algorithm to blood sample images. This research employs a multi-stage methodology, including data preparation, data preprocessing, feature extraction, and then classification. While our model is built on a typical CNN architecture, we make significant advances by using preprocessing techniques and hyperparameter tuning. We have modified its layers combination to include convolutional, pooling, and fully connected layers that are optimized for image characteristics. These layers are fine-tuned for better feature extraction and classification accuracy. This study showed that blood cell detection for diagnosing acute leukemia based on images had 99% accuracy and outperformed other advanced models, including DenseNet121, ResNet-50, Incep-tionv3, MobileNet, and EfficientNet. The comprehensive analysis of the results reveals the highest accuracy of leukemia detection as compared to existing studies in the relevant literature.


  • Open Access

    Linear programming based computational technique for leukemia classification using gene expression profile

    by Mahwish Ilyas, Khalid Mahmood Aamir, Sana Manzoor, Mohamed Deriche

    Cancer is a serious public health concern worldwide and is the leading cause of death. Blood cancer is one of the most dangerous types of cancer. Leukemia is a type of cancer that affects the blood cell and bone marrow. Acute leukemia is a chronic condition that is fatal if left untreated. A timely, reliable, and accurate diagnosis of leukemia at an early stage is critical to treating and preserving patients’ lives. There are four types of leukemia, namely acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic in extracting, and chronic myelogenous leukemia. Recognizing these cancerous development cells is often done via manual analysis of microscopic images. This requires an extraordinarily skilled pathologist. Leukemia symptoms might include lethargy, a lack of energy, a pale complexion, recurrent infections, and easy bleeding or bruising. One of the challenges in this area is identifying subtypes of leukemia for specialized treatment. This Study is carried out to increase the precision of diagnosis to assist in the development of personalized plans for treatment, and improve general leukemia-related healthcare practises. In this research, we used leukemia gene expression data from Curated Microarray Database (CuMiDa). Microarrays are ideal for studying cancer, however, categorizing the expression pattern of microarray information can be challenging. This proposed study uses feature selection methods and machine learning techniques to predict and classify subtypes of leukemia in gene expression data CuMiDa (GSE9476). This research work utilized linear programming (LP) as a machine-learning technique for classification. Linear programming model classifies and predicts the subtypes of leukemia Bone_Marrow_CD34, Bone Marrow, AML, PB, and PBSC CD34. Before using the LP model, we selected 25 features from the given dataset of 22283 features. These 25 significant features were the most distinguishing for classification. The classification accuracy of this work is 98.44%.